logo

Iovance Biotherapeutics Inc (IOVA) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Iovance Biotherapeutics Inc’s current trading price is -17.62% away from its 52-week high, while its distance from the 52-week low is 370.40%. The stock’s price range over this period has fluctuated between $3.21 and $18.33. The company, operating within the financial sector, had a trading volume of approximately 7.92 million for the day, which was noticeably lower than the average daily share volume of 10.72 million over the last 3 months.

In terms of market performance, Iovance Biotherapeutics Inc had a fairly even. The highest value for the stock in the past year was $18.33 on 02/28/24, and the lowest value was recorded at $3.21 on 10/19/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Iovance Biotherapeutics Inc (IOVA) has experienced a quarterly rise of 124.37% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.22B and boasts a workforce of 557 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 8.07, with a change in price of +11.53. Similarly, Iovance Biotherapeutics Inc recorded 9,133,868 in trading volume during the last 100 days, posting a change of +322.97%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for IOVA stands at 0.13. Similarly, the long-term debt-to-equity ratio is also 0.12.

IOVA Stock Stochastic Average

Today’s raw stochastic average for Iovance Biotherapeutics Inc over the last 50 days is 70.65%.This indicates a increase from the raw stochastic average of the past 20 days, which was 65.82%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 74.02% and 80.22%, respectively.

IOVA Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 85.73%. However, over the past six months, we’ve seen a weaker performance of 153.78%. The price of IOVA fallen by 73.96% over the last 30 days. And in the last five days, it has fallen by -10.97%.